STTK - Shattuck Labs, Inc.

0.9104
-0.390   -42.794%

Share volume: 507,105
Last Updated: 04-08-2025
Pharmaceutical Products/Pharmaceutical Preparations: 0.05%

PREVIOUS CLOSE
CHG
CHG%
$1.30
-0.39
-0.30%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
12%
Profitability 0%
Dept financing 4%
Liquidity 75%
Performance 10%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
24.20%
1 Month
-25.98%
3 Months
-23.50%
6 Months
-34.97%
1 Year
-89.88%
2 Year
-69.65%
Key data
Stock price
$0.91
P/E Ratio 
0.00
DAY RANGE
$0.87 - $1.12
EPS 
-$0.37
52 WEEK RANGE
$0.69 - $11.76
52 WEEK CHANGE
-$90.67
MARKET CAP 
57.765 M
YIELD 
N/A
SHARES OUTSTANDING 
47.727 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-01-2025
BETA 
0.67
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$626,048
AVERAGE 30 VOLUME 
$267,475
Company detail
CEO: Taylor H. Schreiber
Region: US
Website: shattucklabs.com
Employees: 100
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Recent news
loading